このエピソードについて
Kistein Monkhouse is the Founder of Patient Orator, a start-up that is focused on providing services to racial and ethnic minorities, lower-income communities, the elderly, LGBT communities and other people who are marginalized or underrepresented in receiving healthcare.
With a focus on systemic racism and implicit bias, this app is being developed to help patients overcome communication barriers, data silos, and the imbalance of power between the patient and medical professionals. Addressing the social determinants of health SDOH is top of mind in the improvement of population health particularly in the age of COVID-19.
@patientorator #patientdata #populationhealth #precisionhealth #socialdeterminantsofhealth #SDOH #healthcaredata #COVID19
英語
アメリカ合衆国
このポッドキャストの他のエピソード
Richard Foust, President and CEO of Mobia Medical, discusses their FDA-approved implantable neurostimulation technology designed to improve hand and arm function in ischemic stroke survivors. When paired with task-specific rehabilitation therapy, this process enhances neuroplasticity, allowing the…
Richard Foust, President and CEO of Mobia Medical, discusses their FDA-approved implantable neurostimulation technology designed to improve hand and arm function in ischemic stroke survivors. When paired with task-specific rehabilitation therapy, this process enhances neuroplasticity, allowing the…
Rae McMahan, Senior VP for Payer Solutions at Prescryptive, points out how the surge in demand for GLP-1 medications has exposed the strengths and weaknesses of the pharmaceutical ecosystem. Rae highlights the growing role of direct-to-patient and manufacturer-sponsored programs as an alternative …
Rae McMahan, Senior VP for Payer Solutions at Prescryptive, points out how the surge in demand for GLP-1 medications has exposed the strengths and weaknesses of the pharmaceutical ecosystem. Rae highlights the growing role of direct-to-patient and manufacturer-sponsored programs as an alternative …
John Hanna, President and CEO of CareDx, discussed how the company's blood-based molecular diagnostic testing is transforming patient monitoring for organ transplantation, HPV-driven cancers, and hematologic malignancies. These molecular tools provide early warning signals months ahead of conventi…
免責: このページに埋め込まれているポッドキャストとアートワークは Karen Jagoda からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
